A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Kamlesh Sodani, Amit K. Tiwari, Chun-Ling Dai, Alaa H. Abuznait, Atish Patel, Zhi-Jie Xiao, Charles R. Ashby, Amal Kaddoumi, Li-Wu Fu, Zhe-Sheng Chen, Sildenafil Enhances the Anticancer Activity of Paclitaxel in an ABCB1-Mediated Multidrug Resistance Xenograft Mouse Model , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- Jia-Jie Shi, Ling-Hua Meng, Autophagy in Cancer Therapy: Progress and Issues , Journal of Cancer Research Updates: Vol. 4 No. 1 (2015)
- Maria Teresa Piccolo, Stefania Crispi, The Dual Role Played by p21 May Influence the Apoptotic or Anti-Apoptotic Fate in Cancer , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- L.R. Morgan, R.S. Weiner, M.L. Ware, M. Bhandari, T. Mahmood, P. Friedlander, Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies , Journal of Cancer Research Updates: Vol. 7 No. 3 (2018)
- Ghazala H. Rizwani, De-Shen Wang, Mansoor Ahmed, Amir Hassan, Zheng-Rong Lai, Affnan Zahid, Najia Mansoor, Huma Sharif, Zhe-Sheng Chen, Zhi Shi, Anticancer Activity of Five Traditionally Used Medicinal Plants' Extracts , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- S.K. Gantsev, V.Y. Gorbunova, G.F. Galikeeva, E.V. Vorobyeva, E.M. Vasilyeva, R.A. Rustamhanov, Molecular Genetic Study of the Allelic State of the Cell Cycle Genes (TP53, BRCA1) and Features of the Regulation of the Cytokine Cascade in Breast Cancer , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
- Teoh Han Pinn, Siti Fathiah Masre, Nadiah Abu, MiR-130b-3p Suppress the Migration, Proliferation and Chemosensitization of Hepatocellular Carcinoma Cells , Journal of Cancer Research Updates: Vol. 13 (2024)
- Giovanni Luigi Capella, Do "Incidental Melanomas" Exist? If so, how many are they? High Time to Decide , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Jamison Wijaya, Indrayadi Gunardi, Julvyn Julvyn, Christopher Lim, Benny Nicolas Johannis, Firstine Kelsi Hartanto, Adrianus Rajasa, Rahmi Amtha, Elizabeth Fitriana Sari, Selecting the Appropriate Oral Cancer Cell Line: Characteristic-Based Recommendations from a Systematic Review , Journal of Cancer Research Updates: Vol. 14 (2025)
- Abdul Rashid Lone, Shiekh Aejaz Aziz, Mohmad Hussain Mir, Sumyra K. Qadri, Arif N. Bhat, Farhana S. Bagdadi, Syed Nisar, Ulfat Ara, Case Report: Primary Squamous Cell Carcinoma of Kidney-An Unusual Malignancy , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)